Work

Phase 1 expansion study of FF-10832 (liposomal gemcitabine) antitumor activity in patients with advanced biliary carcinomas.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.4092

Authors: Gerald Steven Falchook, Erkut H. Borazanci, Bruce Shih-Li Lin, Junaid Arshad, Jason Timothy Henry, Aaron J. Scott, Kin Cheung, Mary Johansen, Timothy Madden, Gary Maier, Mikinaga Mori, Susumu Shimoyama, Ruth Ann Subach, David S. Wages, Naoki Yamada, Rachna T. Shroff

Institutions: HealthONE, HonorHealth, Virginia Mason Medical Center, University of Arizona Cancer Center, Fujifilm (Japan), Fujifilm (United States)

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410817024

Cites:

Cited by:

Related to: 10